GAD 65
About
Glutamic Acid Decarboxylase (GAD) 65 autoantibodies have been related to a variety of diseases. Because they are present in 80 percent of patients upon diagnosis, these antibodies are extensively employed as biomarkers for diabetes mellitus type 1 (DM1).
